HENDERSON JOHN T bought CYTK
May 5, 2026 · Form 4 insider transaction
HENDERSON JOHN T bought 20,000 shares of Cytokinetics, Incorporated at $7.61 per share, a transaction worth $152.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$7.61
Total value
$152.2K
InsiderHENDERSON JOHN T
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 5, 2026
Filing dateMay 5, 2026
Shares owned after95,237
OwnershipDirect
10b5-1 planNo
AmendedNo